Glycogenin-2 is dispensable for liver glycogen synthesis and glucagon-stimulated glucose release

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 5, 2015, Pages E767-E775

  Irgens, Henrik U ^a,b   Fjeld, Karianne ^a,b   Johansson, Bente B ^a,b   Ringdal, Monika ^a,b   Immervoll, Heike ^a,b   Leh, Sabine ^a,b   Søvik, Oddmund ^a   Johansson, Stefan ^a,b   Molven, Anders ^a,b   Njølstad, Pål R ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; GLYCOGEN; GLYCOGENIN; GLYCOGENIN 2; INSULIN; MESSENGER RNA; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLUCOSYLTRANSFERASE; GLYCOGEN LIVER LEVEL; GYG2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; GYG1 GENE; GYG2 GENE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MIDDLE AGED; PRIORITY JOURNAL; YOUNG ADULT; BIOSYNTHESIS; CARBOHYDRATE METABOLISM; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; LIVER; METABOLISM;

ADULT; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; FEMALE; GLUCAGON; GLUCOSYLTRANSFERASES; HUMANS; LIVER; LIVER GLYCOGEN; MALE; MIDDLE AGED;

EID: 84929311490     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4337     Document Type: Article

References (23)

1. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J. 2012;441:763-787.
2. Nilsson J, Halim A, Larsson E, et al. LC-MS/MS characterization of combined glycogenin-1 and glycogenin-2 enzymatic activities reveals their self-glucosylation preferences. Biochim Biophys Acta. 2014;1844:398-405.
3. Pitcher J, Smythe C, Cohen P. Glycogenin is the priming glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal muscle. Eur J Biochem. 1988;176:391-395.
4. Mu J, Roach PJ. Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism. J Biol Chem. 1998;273:34850-34856.
5. Zhai L, Schroeder J, Skurat AV, Roach PJ. Do rodents have a gene encoding glycogenin-2, the liver isoform of the self-glucosylating initiator of glycogen synthesis? IUBMB Life. 2001;51:87-91.
6. Mu J, Skurat AV, Roach PJ. Glycogenin-2, a novel self-glucosylating protein involved in liver glycogen biosynthesis. J Biol Chem. 1997;272:27589-27597.
7. Molven A, Njølstad PR. Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn. 2011;11:313-320.
8. Edghill EL, Bingham C, Slingerland AS, et al. Hepatocyte nuclear factor-1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet Med. 2006;23:1301-1306.
9. Carette C, Dubois-Laforgue D, Saint-Martin C, et al. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med. 2010;27:1454-1458.
10. Irgens HU, Molnes J, Johansson BB, et al. Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry. Diabetologia. 2013;56:1512-1519.
11. Eder A, Goldman M, Rossmann S, Waxman D, Bianco C. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev. 2009;23:205-220.
12. Søvik O, Heiervang E, Aksnes L, Selvig S. Responses of plasma adenosine 3′,5′-monophosphate, blood glucose and plasma insulin to glucagon in humans. Scand J Clin Lab Med. 1981;41:669-674.
13. Johnson NC. XC: the forgotten blood group system. Immunohematology. 2011;27:68-71.
14. Moslemi AR, Lindberg C, Nilsson J, Tajsharghi H, Andersson B, Oldfors A. Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med. 2010;362:1203-1210.
15. Kollberg G, Tulinius M, Gilljam T, et al. Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0. N Engl J Med. 2007;357:1507-1514.
16. Orho M, Bosshard NU, Buist NR, et al. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest. 1998;102:507-515.
17. Imagawa E, Osaka H, Yamashita A, et al. A hemizygous GYG2 mutation and Leigh syndrome: a possible link? Hum Genet 2014;133:225-234.
18. Ramnanan CJ, Edgerton DS, Kraft G, Cherrington AD. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab. 2011;13(suppl 1):118-125.
19. Franzese A, Iorio R, Buono P, Mascolo M, Mozzillo E, Valerio G. Mauriac syndrome still exists. Diabetes Res Clin Pract. 2001;54:219-221.
20. Chokkalingam K, Tsintzas K, Snaar JE, et al. Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study. Diabetologia. 2007;50:1921-1929.
21. 13C MRS study. NMR Biomed. 2013;26:1518-1526.
22. 1000 Genomes Project Consortium, Abecasis GR, Auton A, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
23. ExAC Browser (Beta)|Exome Aggregation Consortium. Exome sequencing data from 61 486 unrelated individuals. http://exac.broadinstitute.org. Accessed November 10, 2014.